An application made for this job — a tailored resume and cover letter that speak straight to the posting.
The Center for Drug Discovery at Baylor College of Medicine in Houston seeks a Postdoctoral Research Associate to develop and characterize dTAG-KI mouse models for biomedical research. The role employs CRISPR/Cas9, molecular biology, and in vivo experiments to study drug-metabolizing enzymes in vivo, enabling on/off control with dTAG molecules.
NIH R01-funded project; BCM provides NIH-style stipend guidance.
Monday - Friday, 8 a.m. - 5 p.m.
The Center for Drug Discovery ( https://www.bcm.edu/research/centers/drug-discovery) is a strategic research center at Baylor College of Medicine in Houston, Texas. The lab is seeking a highly self-motivated Postdoctoral Research Associate to develop and characterize dTAG knock-in (dTAG-KI) mouse models for biomedical and pharmacological research as part of an NIH R01-funded project. The Postdoctoral Associate will use CRISPR/Cas9 genome-editing technology, molecular biology techniques, and animal experimentation to investigate the regulation and function of drug metabolizing enzyme in vivo. It provides a highly reliable tool for Drug Metabolism and Pharmacokinetics (DMPK) studies to understand the impact of a specific drug-metabolizing enzyme deficiency on drug efficacy and safety by switching the function completely on or off using dTAG molecules. The position offers an opportunity to gain advanced training in genome engineering, conditional protein degradation, animal-model development, and translational pharmacology.
Baylor College of Medicine typically follows similar to the NIH stipulated stipend guidelines for Postdoctoral Associates.
Requisition ID: 26106